(Q71669530)
Statements
Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia (English)
Carella AM
Podestá M
Pungolino E
Pollicardo N
Ferrero R